I'm not sure if the ease of distribution is enough of a differentiator imo. TLX gozellix kit appears to have a good shelf life which nullifies this. Efficacy in the guise of sensitivity for a diagnostic will be the main attractor for clinicians wanting to use cu6, if cu64 ends up with a much higher sensitivity.
- Forums
- ASX - By Stock
- CU6
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
2.69%
!
$2.29

Ann: First patient imaged in Phase III AMPLIFY trial, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
0.060(2.69%) |
Mkt cap ! $739.1M |
Open | High | Low | Value | Volume |
$2.30 | $2.37 | $2.21 | $4.838M | 2.103M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 11509 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 2596 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 11509 | 2.280 |
11 | 60573 | 2.270 |
10 | 62875 | 2.260 |
12 | 43052 | 2.250 |
3 | 207405 | 2.240 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 2056 | 13 |
2.300 | 36480 | 31 |
2.310 | 9691 | 20 |
2.320 | 21904 | 14 |
2.330 | 17130 | 7 |
Last trade - 13.55pm 17/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online